Category - Executive Moves

Executive Moves

Cantor expands healthcare equity research

Cantor Fitzgerald expanded its healthcare equity research team with the additions of Louise Chen and Travis Steed. Ms. Chen is joining Cantor as a senior research analyst and managing director, focused on specialty...

June 15, 2017

Executive Moves

Karen Koski joins Oxford Immunotec as head of strategy

Oxford Immunotec Global (NASDAQ:OXFD) has appointed Karen Koski as head of strategy and investor relations, a newly created position that will report directly to CEO, Peter Wrighton-Smith. The appointment is effective...

June 7, 2017

Executive Moves

Ladenburg starts Catalyst at buy

Ladenburg Thalmann initiated coverage of Catalyst Biosciences (NASDAQ:CBIO) with a ‘buy” rating and $11.00 price target. The stock closed at $4.17 on June 5.

June 6, 2017

Executive Moves

Braeburn names Mike Derkacz as president, CEO

Closely held Braeburn Pharmaceuticals appointed Michael Derkacz as president and CEO, succeeding Behshad Sheldon, who is stepping down from both posts and as a director, effective immediately, but will continue to serve...

June 5, 2017

Executive Moves

Roth hires Eric Cheng to head healthcare investment banking

Closely-held Roth Capital Partners named Eric Cheng as managing director, head of healthcare investment banking.

April 27, 2017

Executive Moves

Duff & Phelps expands healthcare M&A team

Duff & Phelps has added managing director Phil Smith and director Adam Stormoen to its healthcare M&A advisory practice in Minneapolis. Mr. Smith has more than 25 years of healthcare transaction experience as an...

April 21, 2017

Executive Moves

3DS names Dr. Kevin Little as CSO

3D Signatures (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) appointed Dr. Kevin Little, a leading biomedical scientist and corporate executive, as its new chief scientific officer, effective immediately.

April 11, 2017